Market Overview:
The global medical rigid foam market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for medical devices and components, rising awareness about hygiene and safety, and growing number of surgical procedures. In terms of type, the polyurethane segment is expected to lead the global medical rigid foam market during the forecast period. This can be attributed to its properties such as high thermal insulation, good acoustic insulation, and resistance against chemicals.
Product Definition:
A rigid foam is a type of insulation that is made from polystyrene or polyurethane. It is used in many different applications, including medical devices. Medical rigid foam can be used to create custom-shaped implants and prostheses. It can also be used as a filler material in medical devices such as catheters and stents.
Polyurethane:
Polyurethane (PU) is a foaming plastic with excellent insulation properties. It is widely used in the manufacturing of rigid foam based products such as bedding, furniture, and automotive components. The growth factor for PU in medical rigid foam market can be attributed to its ability to provide thermal insulation and soundproofing characteristics at an affordable price point.
Polystyrene:
Polystyrene is a crystalline solid that is resistant to most solvents and temperatures. It has a low density of 0.94 g/cm3 and can be molded into any shape easily. The material possesses excellent chemical, electrical, and thermal properties making it ideal for various industries such as automotive & transportation, packaging (food & beverage), electronics, construction materials (insulation), consumer goods, etc.
Application Insights:
Medical packaging was the dominant application segment and accounted for a revenue share of around 60.0% in 2017. The medical rigid foam is used as an insulating material in various medical devices, such as incubators, coolers and ventilators. It is also used to manufacture surgical drapes, patient mattresses and seating cushions among others.
Rise in demand for rigid foams from prosthetics & wound care manufacturers on account of their ability to provide customized shapes, sizes and colors is expected to drive the product demand over the forecast period. In addition, stringent regulatory standards pertaining to hygiene maintenance of wounds are anticipated to augment market growth over the coming years.
Regional Analysis:
North America was the leading global market in 2017. The region is expected to maintain its position through the forecast period owing to high demand for rigid foam products from various end-use industries, such as medical devices and packaging. In addition, rising healthcare expenditure by governments and consumers is anticipated to drive industry growth over the next eight years.
Asia Pacific is estimated to be the fastest-growing regional segment over the forecast period owing to rapid economic development in emerging countries of China and India along with other South East Asian nations.
Growth Factors:
- Increasing demand for medical rigid foam in the orthopedic and dental implants industry.
- Rising demand for lightweight and energy-efficient materials in the automotive industry.
- Growing use of medical rigid foam in prosthetic devices and other medical applications.
- Technological advancements that are resulting in new applications for medical rigid foam products.
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Rigid Foam Market Research Report
By Type
Polyurethane, Polystyrene, Polyvinyl Chloride, Polyolefin, Others
By Application
Medical Packaging, Medical Devices & Components, Prosthetics & Wound Care, Others
By Companies
Sekisui Chemical Co, Ltd. (Japan), BASF SE (Germany), The Dow Chemical Company (U.S.), Bayer AG (Germany), Sekisui Chemical Co, Ltd. (Japan)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Medical Rigid Foam Market Report Segments:
The global Medical Rigid Foam market is segmented on the basis of:
Types
Polyurethane, Polystyrene, Polyvinyl Chloride, Polyolefin, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Packaging, Medical Devices & Components, Prosthetics & Wound Care, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sekisui Chemical Co, Ltd. (Japan)
- BASF SE (Germany)
- The Dow Chemical Company (U.S.)
- Bayer AG (Germany)
- Sekisui Chemical Co, Ltd. (Japan)
Highlights of The Medical Rigid Foam Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polyurethane
- Polystyrene
- Polyvinyl Chloride
- Polyolefin
- Others
- By Application:
- Medical Packaging
- Medical Devices & Components
- Prosthetics & Wound Care
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Rigid Foam Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical rigid foam is a type of medical grade foam that is used to create custom orthopedic and sports braces. It is made from a blend of polyurethane and plastic, which makes it strong and durable. Medical rigid foam can be customized to fit specific needs, making it an ideal option for patients who need specialized braces.
Some of the key players operating in the medical rigid foam market are Sekisui Chemical Co, Ltd. (Japan), BASF SE (Germany), The Dow Chemical Company (U.S.), Bayer AG (Germany), Sekisui Chemical Co, Ltd. (Japan).
The medical rigid foam market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Rigid Foam Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Rigid Foam Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Rigid Foam Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Rigid Foam Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Rigid Foam Market Size & Forecast, 2020-2028
4.5.1 Medical Rigid Foam Market Size and Y-o-Y Growth
4.5.2 Medical Rigid Foam Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Polyurethane
5.2.2 Polystyrene
5.2.3 Polyvinyl Chloride
5.2.4 Polyolefin
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Medical Packaging
6.2.2 Medical Devices & Components
6.2.3 Prosthetics & Wound Care
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Rigid Foam Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Rigid Foam Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Polyurethane
9.6.2 Polystyrene
9.6.3 Polyvinyl Chloride
9.6.4 Polyolefin
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Medical Packaging
9.10.2 Medical Devices & Components
9.10.3 Prosthetics & Wound Care
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Polyurethane
10.6.2 Polystyrene
10.6.3 Polyvinyl Chloride
10.6.4 Polyolefin
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Medical Packaging
10.10.2 Medical Devices & Components
10.10.3 Prosthetics & Wound Care
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Polyurethane
11.6.2 Polystyrene
11.6.3 Polyvinyl Chloride
11.6.4 Polyolefin
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Medical Packaging
11.10.2 Medical Devices & Components
11.10.3 Prosthetics & Wound Care
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Polyurethane
12.6.2 Polystyrene
12.6.3 Polyvinyl Chloride
12.6.4 Polyolefin
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Medical Packaging
12.10.2 Medical Devices & Components
12.10.3 Prosthetics & Wound Care
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Polyurethane
13.6.2 Polystyrene
13.6.3 Polyvinyl Chloride
13.6.4 Polyolefin
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Medical Packaging
13.10.2 Medical Devices & Components
13.10.3 Prosthetics & Wound Care
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Rigid Foam Market: Competitive Dashboard
14.2 Global Medical Rigid Foam Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sekisui Chemical Co, Ltd. (Japan)
14.3.2 BASF SE (Germany)
14.3.3 The Dow Chemical Company (U.S.)
14.3.4 Bayer AG (Germany)
14.3.5 Sekisui Chemical Co, Ltd. (Japan)
